Watch-List Play ITNS .0164 News: Charles Hensley, Ph.D., and Itonis Pharmaceuticals Announce Anti-HIV Compound Targeting the Viral Entry Step
IRVINE, CA, Oct 03, 2012 (MARKETWIRE via COMTEX) -- Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and the founding President of Itonis Pharmaceuticals, are pleased to announce their second product offering since the formation of Itonis Pharmaceuticals as a division of Itonis, Inc. The new product offering, details of which will be revealed over the coming weeks, is an anti-HIV preparation that is based entirely on natural compounds.
Dr. Hensley commented, "Along with the preparation for the anti-nausea product we recently announced, we have been perfecting our anti-HIV technology. One attractive aspect of this technology is that it targets the viral entry step that gives it a broad application base. It is very important to protect this intellectual property before disseminating the specifics of the compound. We expect the process of protecting this valuable technology to begin over the coming weeks."
Itonis Pharmaceuticals recently announced that it will begin organizing clinical trials for its over-the-counter, systemically active anti-nausea preparation delivered via a nasal and/or sublingual spray for the alleviation of mild to moderate nausea. It also expects to begin organizing clinical trials for this new anti-HIV technology over the coming weeks.
About Itonis, Inc. and Itonis Pharmaceuticals
Itonis Pharmaceuticals is a new division of Itonis, Inc. that Itonis expects to convert into a new subsidiary. The division's mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. These preparations will be categorized as derivative pharmaceuticals in that while the preparations will be both safe and effective, the path to market is faster than traditional pharmaceutical drugs. Dr. Charles Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of Geltech, LLC that launched the Zicam(R) Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.
For information on Itonis, Inc., please visit www.itonisholdings.com.
Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Contact:
Michael Biddick
Email Contact
(949) 529-1588
SOURCE: Itonis, Inc.
Watch-List Play ITNS .0164 News: Charles Hensley, Ph.D.,
Top 10 Most Recent News Articles
Once Upon a Coconut Supports Breast Cancer Cause
Supporting Breast Cancer Awareness When a coconut water brand shifts to pink, it's not just about changing colors—it's a signal of commitment. Every October, the world paints itself pink to stand against breast cancer, and Once Upon a Coconut is no different. This year, they're diving headfirst into Breast Cancer Awareness Month with their limited-edition pink cans, all...
Continue Reading
New Leadership at Newmark: Tech Focus Amplified
A Strategic Leap in Tech Leadership Newmark Group, Inc. (NASDAQ: NMRK) has handed the digital reins to Mike Whitaker, bringing him on board as Group Chief Information Officer. If you're in the loop with commercial real estate, this shakeup shouldn't come as a surprise. Newmark's been pretty gung-ho about tightening their tech playbook, and Whitaker's appointment is just...
Continue Reading
Elevest's Fund 70: High Hopes in Dallas Tower Deal
Aiming High in the Heart of Dallas Rolling the dice in downtown Dallas isn't for the faint-hearted, but Elevest Capital is strutting in with swagger. Their 70th fund acquisition—a 229-unit high-rise—is rocking the highest going-in cap rate the firm has ever snagged at 6.4%. Built in 2007 and lounging at a comfy 93% occupancy with zero concessions, this property sure...
Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Primrose Schools App: A Bold Step for Digital Literacy
Primrose Schools Delivers a New Era in Child Education Sitting at a crossroads between the tactile charm of hands-on learning and the inevitable march of digital literacy, Primrose Schools has unveiled something that might just rock the boat in early education: their new Balanced Learning® App. This move by Primrose comes at a crucial time when many parents are...
Continue Reading
Class Action Lawsuit Hits Desert Resort Management
Desert Resort Management in Labor Hot Seat Alright, here's a twist that might make your coffee spill—Desert Resort Management, Inc. is caught in a legal whirlwind in Riverside County. The heavy hitters at Blumenthal Nordrehaug Bhowmik De Blouw LLP have slapped a lawsuit right in their face, alleging some grimy labor practices. They're claiming that the company wasn't...
Continue Reading
Appy Pie Secures Patent for AI Driven App Building
A New Dawn in App Creation You ever think about a world where creating an app is as straightforward as chatting with an old buddy? Well, that future's knocking at the door, courtesy of Appy Pie. They're ruffling feathers with a shiny new U.S. patent promising just that—apps whipped into shape by a bit of chitchat with their AI-powered platform. It's got folks scratching...
Continue Reading
AHN Healthcare@Home Celebrates Fourth Top Workplace Win
Four-Time Top Workplace Champ You want to talk consistency? Let's talk about AHN Healthcare@Home pulling in that Pittsburgh Top Workplace award four years running. It's no small feat, especially in the healthcare sector where employee burnout isn't just a buzzword—it's a daily challenge. How did a home health and hospice outfit like AHN land this honor? Well, it's all...
Continue Reading
RiskScout Rides High on Funding, Tackles Financial Crime
A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...
Continue ReadingTop 5 Most Recently Viewed Articles
Celebrating HII's Employees at the Women of Color STEM Awards
HII Celebrates Diversity and Excellence in STEM HII, renowned for its innovations in national defense and advanced technologies, proudly honors 15 of its dedicated employees who showcased exceptional contributions in the fields of science, technology, engineering, and mathematics (STEM) at a prestigious event. This recognition took place at the annual Women of Color STEM...
Continue Reading
Titan International's Q4 Performance & 2025 Projections Explained
Titan International, Inc. Reports Fourth Quarter Financial Results Titan International, Inc. (NYSE: TWI), a prominent global manufacturer of off-highway wheels and tires, recently released their financial results for the fourth quarter and fiscal year ending December 31, 2024. The company highlighted significant achievements in cash flow and marked a successful...
Continue Reading
Navigating the Shadows of Earnings Reports: Traders Beware
So, let's get straight to it—earnings reports are like riddles wrapped in mysteries. You think you’re just reading numbers, but nah, it’s a deep dive into corporate guts and glory. And when those earnings come out, they set the tone for stocks to either fly high or crash hard. Here’s the deal: Earnings Per Share (EPS) is that go-to figure everyone obsesses over....
Continue Reading
VUNO Accelerates Global Expansion with CE MDR and UKCA Approvals
Regulatory Approvals for VUNO's Innovative Solutions VUNO, a prominent player in the medical AI field, has recently achieved significant regulatory milestones with the CE MDR and UKCA certifications for its AI-powered cardiac arrest risk management system, VUNO Med®-DeepCARS®. These approvals mark a decisive step in the company's plans to enhance healthcare offerings...
Continue Reading
Nova Leap Health Corporation Reports Promising Q1 2025 Performance
Nova Leap Health Corp.'s Q1 2025 Financial Highlights NOVA LEAP HEALTH CORP. (TSXV: NLH) is excited to share its financial results for the quarter ending March 31, 2025, reflecting the company's positive growth trajectory in the home health care sector. Q1 2025 Performance Overview The latest financial report discloses that Nova Leap achieved revenues of $7,093,624 for...
Continue Reading